ERBB2 and neoplasm: High Content Screening (HCS) fluorescence imaging showed that, upon binding, both trastuzumab and ST8176AA1 are rapidly internalized by ErbB2-expressing tumor cells and are both localized within the cytoplasm (Figure 2C and Supplementary Figure S6).